

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 6.28364719 |
| 2 | sarcomere organization (GO:0045214) | 6.20111479 |
| 3 | cardiac myofibril assembly (GO:0055003) | 5.96850279 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.53826562 |
| 5 | tricarboxylic acid cycle (GO:0006099) | 5.39463132 |
| 6 | cardiac chamber formation (GO:0003207) | 5.25261906 |
| 7 | regulation of cardiac muscle cell contraction (GO:0086004) | 5.18990536 |
| 8 | carnitine shuttle (GO:0006853) | 4.94984668 |
| 9 | myofibril assembly (GO:0030239) | 4.86807079 |
| 10 | fatty acid transmembrane transport (GO:1902001) | 4.86231609 |
| 11 | * bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.83538971 |
| 12 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.79417663 |
| 13 | lysine metabolic process (GO:0006553) | 4.77219531 |
| 14 | lysine catabolic process (GO:0006554) | 4.77219531 |
| 15 | * cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.70873618 |
| 16 | cardiac muscle cell development (GO:0055013) | 4.69710082 |
| 17 | relaxation of cardiac muscle (GO:0055119) | 4.57022810 |
| 18 | cardiac muscle contraction (GO:0060048) | 4.53331857 |
| 19 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.49012585 |
| 20 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.47082290 |
| 21 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.45964861 |
| 22 | * regulation of heart rate (GO:0002027) | 4.41733834 |
| 23 | cardiac cell development (GO:0055006) | 4.39633865 |
| 24 | 2-oxoglutarate metabolic process (GO:0006103) | 4.39572070 |
| 25 | * ventricular cardiac muscle cell action potential (GO:0086005) | 4.38985918 |
| 26 | fatty acid beta-oxidation (GO:0006635) | 4.35624691 |
| 27 | atrial septum morphogenesis (GO:0060413) | 4.30057266 |
| 28 | cardiac ventricle formation (GO:0003211) | 4.21154385 |
| 29 | * cardiac muscle tissue morphogenesis (GO:0055008) | 4.15553586 |
| 30 | regulation of cell communication by electrical coupling (GO:0010649) | 4.14520335 |
| 31 | muscle filament sliding (GO:0030049) | 4.13199654 |
| 32 | actin-myosin filament sliding (GO:0033275) | 4.13199654 |
| 33 | regulation of sequestering of triglyceride (GO:0010889) | 4.11282088 |
| 34 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.09254861 |
| 35 | cardiac muscle hypertrophy (GO:0003300) | 4.05755527 |
| 36 | actomyosin structure organization (GO:0031032) | 4.02094184 |
| 37 | regulation of ATP catabolic process (GO:1903289) | 3.99828699 |
| 38 | regulation of ATPase activity (GO:0043462) | 3.99828699 |
| 39 | heart trabecula formation (GO:0060347) | 3.98430445 |
| 40 | aspartate family amino acid catabolic process (GO:0009068) | 3.98365412 |
| 41 | glyoxylate metabolic process (GO:0046487) | 3.97696072 |
| 42 | * cell communication by electrical coupling (GO:0010644) | 3.95860735 |
| 43 | * cardiac muscle cell action potential (GO:0086001) | 3.94558068 |
| 44 | cardiac right ventricle morphogenesis (GO:0003215) | 3.93968796 |
| 45 | * ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.93696312 |
| 46 | muscle hypertrophy in response to stress (GO:0003299) | 3.91348873 |
| 47 | cardiac muscle adaptation (GO:0014887) | 3.91348873 |
| 48 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.91348873 |
| 49 | fatty acid oxidation (GO:0019395) | 3.89128977 |
| 50 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.88933099 |
| 51 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.88284829 |
| 52 | regulation of cardiac muscle contraction (GO:0055117) | 3.84839551 |
| 53 | lipid oxidation (GO:0034440) | 3.80354860 |
| 54 | adrenergic receptor signaling pathway (GO:0071875) | 3.80249137 |
| 55 | striated muscle hypertrophy (GO:0014897) | 3.77697786 |
| 56 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.76537167 |
| 57 | carnitine transmembrane transport (GO:1902603) | 3.76440390 |
| 58 | * cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.73398154 |
| 59 | fatty acid catabolic process (GO:0009062) | 3.71648156 |
| 60 | acetyl-CoA metabolic process (GO:0006084) | 3.71402565 |
| 61 | atrioventricular valve morphogenesis (GO:0003181) | 3.70430254 |
| 62 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.68744049 |
| 63 | L-phenylalanine metabolic process (GO:0006558) | 3.68744049 |
| 64 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.68101279 |
| 65 | * muscle tissue morphogenesis (GO:0060415) | 3.67735867 |
| 66 | outflow tract septum morphogenesis (GO:0003148) | 3.67131088 |
| 67 | positive regulation of heart rate (GO:0010460) | 3.65442138 |
| 68 | regulation of fatty acid oxidation (GO:0046320) | 3.63361520 |
| 69 | regulation of cofactor metabolic process (GO:0051193) | 3.62933757 |
| 70 | regulation of coenzyme metabolic process (GO:0051196) | 3.62933757 |
| 71 | regulation of cardioblast differentiation (GO:0051890) | 3.61633836 |
| 72 | * cardiac conduction (GO:0061337) | 3.59466646 |
| 73 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.58631449 |
| 74 | amino-acid betaine transport (GO:0015838) | 3.58405380 |
| 75 | carnitine transport (GO:0015879) | 3.58405380 |
| 76 | actin-mediated cell contraction (GO:0070252) | 3.57245844 |
| 77 | * regulation of heart contraction (GO:0008016) | 3.56849927 |
| 78 | adult heart development (GO:0007512) | 3.56424392 |
| 79 | amino-acid betaine metabolic process (GO:0006577) | 3.53453115 |
| 80 | kynurenine metabolic process (GO:0070189) | 3.52947424 |
| 81 | short-chain fatty acid metabolic process (GO:0046459) | 3.52837480 |
| 82 | actin filament-based movement (GO:0030048) | 3.52044232 |
| 83 | embryonic heart tube development (GO:0035050) | 3.50407911 |
| 84 | positive regulation of fatty acid oxidation (GO:0046321) | 3.48788126 |
| 85 | branched-chain amino acid catabolic process (GO:0009083) | 3.48771106 |
| 86 | plasma membrane repair (GO:0001778) | 3.48081975 |
| 87 | NADH metabolic process (GO:0006734) | 3.46219710 |
| 88 | regulation of actin filament-based movement (GO:1903115) | 3.45667639 |
| 89 | positive regulation of heart contraction (GO:0045823) | 3.43973390 |
| 90 | cardiac muscle tissue development (GO:0048738) | 3.42653949 |
| 91 | L-phenylalanine catabolic process (GO:0006559) | 3.42481172 |
| 92 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.42481172 |
| 93 | oxidative phosphorylation (GO:0006119) | 3.40996716 |
| 94 | carnitine metabolic process (GO:0009437) | 3.39152912 |
| 95 | regulation of the force of heart contraction (GO:0002026) | 3.38961190 |
| 96 | negative regulation of myotube differentiation (GO:0010832) | 3.37834710 |
| 97 | regulation of skeletal muscle contraction (GO:0014819) | 3.37777290 |
| 98 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.37363693 |
| 99 | regulation of triglyceride catabolic process (GO:0010896) | 3.35937074 |
| 100 | monocarboxylic acid catabolic process (GO:0072329) | 3.35744708 |
| 101 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.33844275 |
| 102 | cellular ketone body metabolic process (GO:0046950) | 3.32809094 |
| 103 | regulation of sarcomere organization (GO:0060297) | 3.31566007 |
| 104 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.30773588 |
| 105 | muscle hypertrophy (GO:0014896) | 3.30173786 |
| 106 | * cell communication involved in cardiac conduction (GO:0086065) | 3.28707545 |
| 107 | * desmosome organization (GO:0002934) | 3.28428926 |
| 108 | cysteine metabolic process (GO:0006534) | 3.27754778 |
| 109 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.26012767 |
| 110 | detection of calcium ion (GO:0005513) | 3.25393483 |
| 111 | endocardial cushion development (GO:0003197) | 3.23740348 |
| 112 | positive regulation of action potential (GO:0045760) | 3.23027840 |
| 113 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.22254445 |
| 114 | positive regulation of ATP catabolic process (GO:1903291) | 3.21817777 |
| 115 | positive regulation of ATPase activity (GO:0032781) | 3.21817777 |
| 116 | oxaloacetate metabolic process (GO:0006107) | 3.21742528 |
| 117 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.21537490 |
| 118 | positive regulation of cardiac muscle tissue development (GO:0055025) | 3.20330151 |
| 119 | alpha-linolenic acid metabolic process (GO:0036109) | 3.20219216 |
| 120 | epithelial cell-cell adhesion (GO:0090136) | 3.20142352 |
| 121 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.17355096 |
| 122 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.17293789 |
| 123 | phospholipid homeostasis (GO:0055091) | 3.17115822 |
| 124 | ventricular cardiac muscle cell development (GO:0055015) | 3.16640458 |
| 125 | striated muscle contraction (GO:0006941) | 3.14975591 |
| 126 | heart process (GO:0003015) | 3.12027132 |
| 127 | heart contraction (GO:0060047) | 3.12027132 |
| 128 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 3.10059370 |
| 129 | serine family amino acid catabolic process (GO:0009071) | 3.09961617 |
| 130 | regulation of sulfur metabolic process (GO:0042762) | 3.08869627 |
| 131 | branched-chain amino acid metabolic process (GO:0009081) | 3.07239289 |
| 132 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.06670696 |
| 133 | tricarboxylic acid metabolic process (GO:0072350) | 3.06607587 |
| 134 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.05669397 |
| 135 | negative regulation of fibrinolysis (GO:0051918) | 3.02930436 |
| 136 | fatty acid homeostasis (GO:0055089) | 3.02878240 |
| 137 | regulation of cardiac muscle cell proliferation (GO:0060043) | 3.01695394 |
| 138 | sulfur amino acid catabolic process (GO:0000098) | 3.01483456 |
| 139 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.01279041 |
| 140 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.99643751 |
| 141 | ATP synthesis coupled proton transport (GO:0015986) | 2.99643751 |
| 142 | regulation of cardiac muscle tissue development (GO:0055024) | 2.99133776 |
| 143 | homocysteine metabolic process (GO:0050667) | 2.98685211 |
| 144 | aromatic amino acid family catabolic process (GO:0009074) | 2.98422027 |
| 145 | biotin metabolic process (GO:0006768) | 2.97929272 |
| 146 | regulation of relaxation of muscle (GO:1901077) | 2.97276430 |
| 147 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.97174821 |
| 148 | response to caffeine (GO:0031000) | 2.96968613 |
| 149 | regulation of striated muscle contraction (GO:0006942) | 2.96266837 |
| 150 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.94491639 |
| 151 | striated muscle cell development (GO:0055002) | 2.92578069 |
| 152 | relaxation of muscle (GO:0090075) | 2.92213675 |
| 153 | regulation of striated muscle cell apoptotic process (GO:0010662) | 2.92211938 |
| 154 | cardiac septum development (GO:0003279) | 2.92105888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.69927653 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.54391894 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.02331749 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.76147087 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.26231980 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.98339738 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.41559971 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.36292939 |
| 9 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.20889591 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.01758991 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.96276793 |
| 12 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.89774956 |
| 13 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.88547213 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.66942053 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.56587935 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.49041361 |
| 17 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.27176273 |
| 18 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.27176273 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.13447302 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.10441072 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.97316237 |
| 22 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.97045114 |
| 23 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.96952589 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95179405 |
| 25 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.87905892 |
| 26 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.86331555 |
| 27 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.80338630 |
| 28 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.76365962 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73184966 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.72422042 |
| 31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67484135 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65402048 |
| 33 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.63764045 |
| 34 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.61643290 |
| 35 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60914758 |
| 36 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.59852345 |
| 37 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.57903860 |
| 38 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.56118647 |
| 39 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.55653781 |
| 40 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.54184696 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.48725077 |
| 42 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.46127117 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43677172 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.41644056 |
| 45 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.41556444 |
| 46 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41276158 |
| 47 | ATF3_27146783_Chip-Seq_COLON_Human | 1.39349085 |
| 48 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.38720304 |
| 49 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37996665 |
| 50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.37907751 |
| 51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.35474387 |
| 52 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.32809206 |
| 53 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.32398851 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32239612 |
| 55 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.32120981 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31848382 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.31070363 |
| 58 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.29476116 |
| 59 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29034350 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28218992 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28127204 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25631657 |
| 63 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.21620663 |
| 64 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.20991238 |
| 65 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20934248 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18939815 |
| 67 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17442035 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17378756 |
| 69 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17256283 |
| 70 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.15926068 |
| 71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15374710 |
| 72 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.15107294 |
| 73 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15077620 |
| 74 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12746158 |
| 75 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12653778 |
| 76 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11187652 |
| 77 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10269718 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.10049711 |
| 79 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.08588527 |
| 80 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06591568 |
| 81 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.05838166 |
| 82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05182979 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03574480 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02133196 |
| 85 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01813950 |
| 86 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01796917 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00739190 |
| 88 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.00403285 |
| 89 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00112448 |
| 90 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.00088343 |
| 91 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99928942 |
| 92 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.99056510 |
| 93 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.98238676 |
| 94 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.98220144 |
| 95 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97561100 |
| 96 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.94974576 |
| 97 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.94000700 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93589717 |
| 99 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93040038 |
| 100 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92967928 |
| 101 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.92618594 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92223594 |
| 103 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91614067 |
| 104 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.89049173 |
| 105 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.88916459 |
| 106 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88492375 |
| 107 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.88484287 |
| 108 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88387340 |
| 109 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.88251685 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88045144 |
| 111 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.87995340 |
| 112 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.87806038 |
| 113 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.86713778 |
| 114 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.86622284 |
| 115 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.81910917 |
| 116 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81627713 |
| 117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80347047 |
| 118 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.80202711 |
| 119 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.80118690 |
| 120 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80007639 |
| 121 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79103557 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78432364 |
| 123 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77333801 |
| 124 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.77091084 |
| 125 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.76898574 |
| 126 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.76898574 |
| 127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75818748 |
| 128 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.75274670 |
| 129 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.73135222 |
| 130 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.72848753 |
| 131 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.72562590 |
| 132 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72393136 |
| 133 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72330134 |
| 134 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.72230644 |
| 135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71852298 |
| 136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71852298 |
| 137 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71437096 |
| 138 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.70004508 |
| 139 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.69431985 |
| 140 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69235217 |
| 141 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68377850 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.68286803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.99051874 |
| 2 | MP0004084_abnormal_cardiac_muscle | 4.72923242 |
| 3 | MP0004215_abnormal_myocardial_fiber | 3.59371388 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.41995606 |
| 5 | MP0005330_cardiomyopathy | 3.35779151 |
| 6 | MP0005360_urolithiasis | 3.32924079 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.31057506 |
| 8 | MP0003646_muscle_fatigue | 3.25493434 |
| 9 | MP0004036_abnormal_muscle_relaxation | 3.04518953 |
| 10 | MP0000751_myopathy | 2.82677641 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.82217571 |
| 12 | MP0005365_abnormal_bile_salt | 2.80434575 |
| 13 | MP0008775_abnormal_heart_ventricle | 2.62223221 |
| 14 | MP0002972_abnormal_cardiac_muscle | 2.58079284 |
| 15 | MP0000749_muscle_degeneration | 2.43939392 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.36330541 |
| 17 | MP0005385_cardiovascular_system_phenoty | 2.26688019 |
| 18 | MP0001544_abnormal_cardiovascular_syste | 2.26688019 |
| 19 | MP0004130_abnormal_muscle_cell | 2.26181097 |
| 20 | MP0006138_congestive_heart_failure | 2.23902603 |
| 21 | * MP0010630_abnormal_cardiac_muscle | 2.20396347 |
| 22 | MP0003137_abnormal_impulse_conducting | 2.15716254 |
| 23 | MP0005620_abnormal_muscle_contractility | 2.06854602 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 2.04191560 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.98597940 |
| 26 | MP0003221_abnormal_cardiomyocyte_apopto | 1.97072429 |
| 27 | MP0005670_abnormal_white_adipose | 1.96736461 |
| 28 | MP0000750_abnormal_muscle_regeneration | 1.94682167 |
| 29 | MP0004484_altered_response_of | 1.93186906 |
| 30 | MP0002269_muscular_atrophy | 1.87841398 |
| 31 | MP0003252_abnormal_bile_duct | 1.86514318 |
| 32 | MP0010329_abnormal_lipoprotein_level | 1.75549852 |
| 33 | MP0003828_pulmonary_edema | 1.72957490 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.72321096 |
| 35 | MP0006036_abnormal_mitochondrial_physio | 1.68672186 |
| 36 | MP0004085_abnormal_heartbeat | 1.64839815 |
| 37 | MP0005332_abnormal_amino_acid | 1.62909399 |
| 38 | MP0000537_abnormal_urethra_morphology | 1.59129357 |
| 39 | MP0001661_extended_life_span | 1.59076954 |
| 40 | MP0002127_abnormal_cardiovascular_syste | 1.52650404 |
| 41 | MP0003567_abnormal_fetal_cardiomyocyte | 1.51456684 |
| 42 | MP0003950_abnormal_plasma_membrane | 1.50528475 |
| 43 | MP0002106_abnormal_muscle_physiology | 1.47964144 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.46645810 |
| 45 | MP0005083_abnormal_biliary_tract | 1.45582602 |
| 46 | MP0009840_abnormal_foam_cell | 1.44590161 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.38453287 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.35175119 |
| 49 | MP0000579_abnormal_nail_morphology | 1.31804366 |
| 50 | MP0005319_abnormal_enzyme/_coenzyme | 1.30553674 |
| 51 | MP0001666_abnormal_nutrient_absorption | 1.27184319 |
| 52 | MP0004510_myositis | 1.25319676 |
| 53 | MP0000462_abnormal_digestive_system | 1.21465763 |
| 54 | MP0008004_abnormal_stomach_pH | 1.19697624 |
| 55 | MP0004272_abnormal_basement_membrane | 1.17658446 |
| 56 | MP0005451_abnormal_body_composition | 1.17586839 |
| 57 | MP0000747_muscle_weakness | 1.16912800 |
| 58 | MP0004233_abnormal_muscle_weight | 1.16461494 |
| 59 | MP0002118_abnormal_lipid_homeostasis | 1.15035060 |
| 60 | MP0005369_muscle_phenotype | 1.12495107 |
| 61 | MP0005375_adipose_tissue_phenotype | 1.09519461 |
| 62 | MP0000759_abnormal_skeletal_muscle | 1.08701896 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 1.07968827 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.07951828 |
| 65 | MP0005165_increased_susceptibility_to | 1.07820828 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 1.06474457 |
| 67 | MP0002102_abnormal_ear_morphology | 1.05936222 |
| 68 | MP0000609_abnormal_liver_physiology | 1.05285863 |
| 69 | MP0003195_calcinosis | 1.04196781 |
| 70 | * MP0000266_abnormal_heart_morphology | 1.03115240 |
| 71 | MP0010234_abnormal_vibrissa_follicle | 1.02695001 |
| 72 | MP0000467_abnormal_esophagus_morphology | 1.00912520 |
| 73 | MP0005266_abnormal_metabolism | 1.00013799 |
| 74 | MP0003186_abnormal_redox_activity | 0.99611036 |
| 75 | MP0010678_abnormal_skin_adnexa | 0.99514712 |
| 76 | MP0004145_abnormal_muscle_electrophysio | 0.94667653 |
| 77 | MP0000762_abnormal_tongue_morphology | 0.93307304 |
| 78 | MP0003937_abnormal_limbs/digits/tail_de | 0.91208018 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 0.91144256 |
| 80 | MP0002234_abnormal_pharynx_morphology | 0.90773841 |
| 81 | MP0003283_abnormal_digestive_organ | 0.88728283 |
| 82 | MP0009643_abnormal_urine_homeostasis | 0.87316925 |
| 83 | MP0003119_abnormal_digestive_system | 0.86490055 |
| 84 | MP0003984_embryonic_growth_retardation | 0.83692299 |
| 85 | MP0002088_abnormal_embryonic_growth/wei | 0.83683095 |
| 86 | MP0000566_synostosis | 0.82147950 |
| 87 | MP0004019_abnormal_vitamin_homeostasis | 0.80789958 |
| 88 | MP0000383_abnormal_hair_follicle | 0.80120467 |
| 89 | MP0009384_cardiac_valve_regurgitation | 0.77065843 |
| 90 | MP0002971_abnormal_brown_adipose | 0.75760537 |
| 91 | MP0002098_abnormal_vibrissa_morphology | 0.74432586 |
| 92 | * MP0002128_abnormal_blood_circulation | 0.73516106 |
| 93 | MP0005187_abnormal_penis_morphology | 0.70232782 |
| 94 | MP0000343_altered_response_to | 0.70221866 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.69927527 |
| 96 | MP0001672_abnormal_embryogenesis/_devel | 0.69346921 |
| 97 | MP0005380_embryogenesis_phenotype | 0.69346921 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68888731 |
| 99 | MP0002078_abnormal_glucose_homeostasis | 0.67861957 |
| 100 | MP0004043_abnormal_pH_regulation | 0.67587238 |
| 101 | MP0005409_darkened_coat_color | 0.67016162 |
| 102 | MP0004147_increased_porphyrin_level | 0.65429766 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.64582566 |
| 104 | MP0010352_gastrointestinal_tract_polyps | 0.64577047 |
| 105 | MP0003279_aneurysm | 0.64319063 |
| 106 | MP0008438_abnormal_cutaneous_collagen | 0.62831835 |
| 107 | MP0003941_abnormal_skin_development | 0.62068186 |
| 108 | MP0004264_abnormal_extraembryonic_tissu | 0.61238183 |
| 109 | MP0002138_abnormal_hepatobiliary_system | 0.60256054 |
| 110 | MP0000598_abnormal_liver_morphology | 0.60253729 |
| 111 | MP0002254_reproductive_system_inflammat | 0.57771300 |
| 112 | MP0003123_paternal_imprinting | 0.56019321 |
| 113 | MP0009697_abnormal_copulation | 0.56016414 |
| 114 | MP0009053_abnormal_anal_canal | 0.55928627 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.55345734 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.55328129 |
| 117 | MP0002086_abnormal_extraembryonic_tissu | 0.55102135 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.54847179 |
| 119 | MP0002925_abnormal_cardiovascular_devel | 0.53474333 |
| 120 | MP0001764_abnormal_homeostasis | 0.53111711 |
| 121 | MP0003890_abnormal_embryonic-extraembry | 0.53068336 |
| 122 | MP0005275_abnormal_skin_tensile | 0.53009207 |
| 123 | MP0002697_abnormal_eye_size | 0.51169647 |
| 124 | MP0003868_abnormal_feces_composition | 0.47489924 |
| 125 | MP0001697_abnormal_embryo_size | 0.43373101 |
| 126 | MP0001765_abnormal_ion_homeostasis | 0.42213246 |
| 127 | MP0002108_abnormal_muscle_morphology | 0.40865742 |
| 128 | MP0005367_renal/urinary_system_phenotyp | 0.40679620 |
| 129 | MP0000516_abnormal_urinary_system | 0.40679620 |
| 130 | MP0001730_embryonic_growth_arrest | 0.39799559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.48651172 |
| 2 | Ventricular tachycardia (HP:0004756) | 5.81482533 |
| 3 | * Right ventricular cardiomyopathy (HP:0011663) | 5.06086662 |
| 4 | Atrial fibrillation (HP:0005110) | 4.74435091 |
| 5 | Primary atrial arrhythmia (HP:0001692) | 4.43083380 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.39621093 |
| 7 | Lipoatrophy (HP:0100578) | 4.34996014 |
| 8 | Supraventricular tachycardia (HP:0004755) | 4.25963308 |
| 9 | Supraventricular arrhythmia (HP:0005115) | 4.20245761 |
| 10 | Myoglobinuria (HP:0002913) | 4.01076461 |
| 11 | * Syncope (HP:0001279) | 3.99732773 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 3.89251502 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 3.87189040 |
| 14 | Muscle fiber splitting (HP:0003555) | 3.79780369 |
| 15 | * Palpitations (HP:0001962) | 3.64923342 |
| 16 | Hyporeflexia of lower limbs (HP:0002600) | 3.64678264 |
| 17 | Dilated cardiomyopathy (HP:0001644) | 3.61355078 |
| 18 | Hyperammonemia (HP:0001987) | 3.58337249 |
| 19 | Hyperglycinuria (HP:0003108) | 3.50263328 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 3.50113011 |
| 21 | * Ventricular arrhythmia (HP:0004308) | 3.44713422 |
| 22 | Subaortic stenosis (HP:0001682) | 3.44389731 |
| 23 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.44389731 |
| 24 | Ketoacidosis (HP:0001993) | 3.44071192 |
| 25 | Ketosis (HP:0001946) | 3.38991844 |
| 26 | Bundle branch block (HP:0011710) | 3.38774940 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.36315439 |
| 28 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.32771205 |
| 29 | Intrahepatic cholestasis (HP:0001406) | 3.32228262 |
| 30 | Rhabdomyolysis (HP:0003201) | 3.30078371 |
| 31 | Dicarboxylic aciduria (HP:0003215) | 3.27874525 |
| 32 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.27874525 |
| 33 | Atrioventricular block (HP:0001678) | 3.18651144 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.17202192 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 3.17202192 |
| 36 | Cerebral edema (HP:0002181) | 3.16329421 |
| 37 | Exercise-induced myalgia (HP:0003738) | 3.13926484 |
| 38 | Asymmetric septal hypertrophy (HP:0001670) | 3.10942787 |
| 39 | Hyperglycinemia (HP:0002154) | 3.07883078 |
| 40 | Prolonged QT interval (HP:0001657) | 3.04898072 |
| 41 | Heart block (HP:0012722) | 3.04293712 |
| 42 | Xanthomatosis (HP:0000991) | 3.03184032 |
| 43 | Increased connective tissue (HP:0009025) | 3.01158367 |
| 44 | Deep venous thrombosis (HP:0002625) | 2.97708474 |
| 45 | Hypoalphalipoproteinemia (HP:0003233) | 2.97463346 |
| 46 | Abnormal atrioventricular conduction (HP:0005150) | 2.92278711 |
| 47 | Ventricular fibrillation (HP:0001663) | 2.84248383 |
| 48 | Ragged-red muscle fibers (HP:0003200) | 2.83310298 |
| 49 | Hepatic necrosis (HP:0002605) | 2.81827047 |
| 50 | EMG: myopathic abnormalities (HP:0003458) | 2.77256998 |
| 51 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.76660412 |
| 52 | Hypolipoproteinemia (HP:0010981) | 2.73079592 |
| 53 | Hypoplastic left heart (HP:0004383) | 2.68251770 |
| 54 | Patent foramen ovale (HP:0001655) | 2.64332219 |
| 55 | Hypobetalipoproteinemia (HP:0003563) | 2.60749088 |
| 56 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.59571148 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.54993329 |
| 58 | Lethargy (HP:0001254) | 2.54007829 |
| 59 | Acute encephalopathy (HP:0006846) | 2.52858852 |
| 60 | Testicular atrophy (HP:0000029) | 2.51532298 |
| 61 | Abnormality of serum amino acid levels (HP:0003112) | 2.47991720 |
| 62 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.47270548 |
| 63 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.46463781 |
| 64 | Metabolic acidosis (HP:0001942) | 2.45104563 |
| 65 | Hyperlipoproteinemia (HP:0010980) | 2.44954287 |
| 66 | Nausea (HP:0002018) | 2.42699019 |
| 67 | Skin nodule (HP:0200036) | 2.41835762 |
| 68 | Hyperglycemia (HP:0003074) | 2.41333253 |
| 69 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.40616016 |
| 70 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.40410832 |
| 71 | Acute necrotizing encephalopathy (HP:0006965) | 2.36274571 |
| 72 | Abnormality of glycolysis (HP:0004366) | 2.35930574 |
| 73 | Increased serum pyruvate (HP:0003542) | 2.35930574 |
| 74 | Proximal tubulopathy (HP:0000114) | 2.34433080 |
| 75 | Late onset (HP:0003584) | 2.31170726 |
| 76 | Generalized aminoaciduria (HP:0002909) | 2.30859355 |
| 77 | Palmoplantar keratoderma (HP:0000982) | 2.29904783 |
| 78 | Hyperactive renin-angiotensin system (HP:0000841) | 2.29076794 |
| 79 | Neck muscle weakness (HP:0000467) | 2.27105325 |
| 80 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.25733768 |
| 81 | Abnormality of alanine metabolism (HP:0010916) | 2.25733768 |
| 82 | Hyperalaninemia (HP:0003348) | 2.25733768 |
| 83 | Double outlet right ventricle (HP:0001719) | 2.24523693 |
| 84 | Congenital malformation of the right heart (HP:0011723) | 2.24523693 |
| 85 | Distal lower limb muscle weakness (HP:0009053) | 2.22957136 |
| 86 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.22464437 |
| 87 | EMG: neuropathic changes (HP:0003445) | 2.21338246 |
| 88 | Difficulty climbing stairs (HP:0003551) | 2.21156042 |
| 89 | Bradycardia (HP:0001662) | 2.20027501 |
| 90 | Skin pits (HP:0100276) | 2.19396942 |
| 91 | Epidermoid cyst (HP:0200040) | 2.16950373 |
| 92 | Decreased circulating renin level (HP:0003351) | 2.15794836 |
| 93 | Abnormal EKG (HP:0003115) | 2.11142824 |
| 94 | Periauricular skin pits (HP:0100277) | 2.09398322 |
| 95 | Preauricular pit (HP:0004467) | 2.09398322 |
| 96 | Multiple enchondromatosis (HP:0005701) | 2.05483773 |
| 97 | Conjunctival hamartoma (HP:0100780) | 2.03745681 |
| 98 | Hepatocellular necrosis (HP:0001404) | 2.03056668 |
| 99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.01821581 |
| 100 | Lactic acidosis (HP:0003128) | 2.00339772 |
| 101 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.99945487 |
| 102 | Transposition of the great arteries (HP:0001669) | 1.99945487 |
| 103 | Abnormal connection of the cardiac segments (HP:0011545) | 1.99945487 |
| 104 | Difficulty running (HP:0009046) | 1.99411837 |
| 105 | Vomiting (HP:0002013) | 1.98694501 |
| 106 | Abnormality of methionine metabolism (HP:0010901) | 1.98325198 |
| 107 | Hypoglycemic seizures (HP:0002173) | 1.98054837 |
| 108 | Abnormal tarsal ossification (HP:0008369) | 1.97222999 |
| 109 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.94577675 |
| 110 | Left ventricular hypertrophy (HP:0001712) | 1.94390874 |
| 111 | Neonatal death (HP:0003811) | 1.94261064 |
| 112 | Prolonged partial thromboplastin time (HP:0003645) | 1.93620578 |
| 113 | Vascular calcification (HP:0004934) | 1.93326670 |
| 114 | Hypoplastic heart (HP:0001961) | 1.93259545 |
| 115 | Increased muscle lipid content (HP:0009058) | 1.92652345 |
| 116 | Progressive macrocephaly (HP:0004481) | 1.90360190 |
| 117 | Hip contracture (HP:0003273) | 1.90356549 |
| 118 | Rimmed vacuoles (HP:0003805) | 1.89981258 |
| 119 | Esophageal varix (HP:0002040) | 1.89542166 |
| 120 | Increased CSF lactate (HP:0002490) | 1.89169715 |
| 121 | Abnormal pancreas size (HP:0012094) | 1.85766048 |
| 122 | Glycosuria (HP:0003076) | 1.85541946 |
| 123 | Abnormality of urine glucose concentration (HP:0011016) | 1.85541946 |
| 124 | * Sudden cardiac death (HP:0001645) | 1.78457838 |
| 125 | Abnormality of the tricuspid valve (HP:0001702) | 1.75150715 |
| 126 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.73302974 |
| 127 | Areflexia of lower limbs (HP:0002522) | 1.70991570 |
| 128 | Congestive heart failure (HP:0001635) | 1.69301118 |
| 129 | Abnormality of renin-angiotensin system (HP:0000847) | 1.66990509 |
| 130 | Limited hip movement (HP:0008800) | 1.63532774 |
| 131 | Abnormality of the salivary glands (HP:0010286) | 1.61744129 |
| 132 | Renal cortical cysts (HP:0000803) | 1.61393658 |
| 133 | Cardiovascular calcification (HP:0011915) | 1.61166449 |
| 134 | Abnormal biliary tract morphology (HP:0012440) | 1.61102170 |
| 135 | Truncus arteriosus (HP:0001660) | 1.57965297 |
| 136 | Flat acetabular roof (HP:0003180) | 1.56808248 |
| 137 | Toxemia of pregnancy (HP:0100603) | 1.56720887 |
| 138 | Lymphangioma (HP:0100764) | 1.55989226 |
| 139 | Ridged nail (HP:0001807) | 1.50760202 |
| 140 | Prenatal maternal abnormality (HP:0002686) | 1.49805354 |
| 141 | Absent eyebrow (HP:0002223) | 1.45501497 |
| 142 | Coarctation of aorta (HP:0001680) | 1.45273467 |
| 143 | Generalized muscle weakness (HP:0003324) | 1.45061890 |
| 144 | Vertebral clefting (HP:0008428) | 1.41097031 |
| 145 | Conjugated hyperbilirubinemia (HP:0002908) | 1.40392112 |
| 146 | Maternal diabetes (HP:0009800) | 1.39910039 |
| 147 | Central scotoma (HP:0000603) | 1.39696706 |
| 148 | Abnormality of chloride homeostasis (HP:0011422) | 1.38447290 |
| 149 | Plantar hyperkeratosis (HP:0007556) | 1.36196563 |
| 150 | Abnormality of vitamin metabolism (HP:0100508) | 1.33577780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.96294101 |
| 2 | BCKDK | 3.81294620 |
| 3 | PKN2 | 3.69410715 |
| 4 | OBSCN | 3.34575312 |
| 5 | LMTK2 | 3.27733588 |
| 6 | MYLK | 3.22911850 |
| 7 | PDK4 | 3.08946988 |
| 8 | PDK3 | 3.08946988 |
| 9 | STK38L | 2.72512209 |
| 10 | TRIB3 | 2.64237832 |
| 11 | EPHA2 | 2.51100121 |
| 12 | NEK1 | 2.45233621 |
| 13 | PIK3CA | 2.16285704 |
| 14 | DMPK | 2.11169270 |
| 15 | STK39 | 2.04809524 |
| 16 | MST4 | 2.01328035 |
| 17 | STK24 | 1.95035531 |
| 18 | PDK2 | 1.84852085 |
| 19 | LATS1 | 1.82878069 |
| 20 | PHKG1 | 1.69844865 |
| 21 | PHKG2 | 1.69844865 |
| 22 | ZAK | 1.62833111 |
| 23 | PAK3 | 1.55771182 |
| 24 | ACVR1B | 1.55594331 |
| 25 | MAP3K3 | 1.52276917 |
| 26 | TIE1 | 1.51237756 |
| 27 | FLT3 | 1.45578963 |
| 28 | INSRR | 1.37978992 |
| 29 | PLK4 | 1.31875725 |
| 30 | MAP3K12 | 1.30129506 |
| 31 | RIPK1 | 1.29733447 |
| 32 | SIK1 | 1.25477699 |
| 33 | FER | 1.07403110 |
| 34 | CAMK2D | 1.07174131 |
| 35 | LATS2 | 1.04053681 |
| 36 | TNIK | 1.02818841 |
| 37 | CDC42BPA | 1.02736790 |
| 38 | CDK12 | 0.95777292 |
| 39 | PDGFRA | 0.95733043 |
| 40 | ILK | 0.95456516 |
| 41 | PRKAA2 | 0.95339614 |
| 42 | NEK9 | 0.94137359 |
| 43 | RPS6KB2 | 0.93901355 |
| 44 | PINK1 | 0.93565354 |
| 45 | MAP3K5 | 0.93146063 |
| 46 | MAP3K7 | 0.92846846 |
| 47 | MAP2K3 | 0.91653049 |
| 48 | LIMK1 | 0.90807496 |
| 49 | MET | 0.89820828 |
| 50 | STK4 | 0.89551302 |
| 51 | PTK6 | 0.88971851 |
| 52 | TTK | 0.88739196 |
| 53 | WNK4 | 0.87287248 |
| 54 | MAPKAPK3 | 0.86825745 |
| 55 | STK38 | 0.86037679 |
| 56 | PRKD1 | 0.84357377 |
| 57 | FGFR4 | 0.79321938 |
| 58 | FRK | 0.78791424 |
| 59 | GRK7 | 0.77676497 |
| 60 | EPHB2 | 0.77425849 |
| 61 | ROCK1 | 0.77345166 |
| 62 | NME2 | 0.76846775 |
| 63 | MST1R | 0.74960163 |
| 64 | PTK2B | 0.74819668 |
| 65 | DAPK3 | 0.73136147 |
| 66 | ERBB4 | 0.71204018 |
| 67 | OXSR1 | 0.71049023 |
| 68 | NLK | 0.69650940 |
| 69 | PRKAA1 | 0.69636687 |
| 70 | PTK2 | 0.68451847 |
| 71 | MTOR | 0.68319073 |
| 72 | KDR | 0.68259982 |
| 73 | ERN1 | 0.68223114 |
| 74 | TRPM7 | 0.66710020 |
| 75 | MAP2K1 | 0.64114829 |
| 76 | AKT2 | 0.63776263 |
| 77 | CAMK1 | 0.60447093 |
| 78 | AKT3 | 0.54875852 |
| 79 | PBK | 0.54492311 |
| 80 | STK3 | 0.54443608 |
| 81 | CAMK1D | 0.54182293 |
| 82 | EIF2AK3 | 0.53524637 |
| 83 | MAP3K11 | 0.50683790 |
| 84 | EPHA3 | 0.48944184 |
| 85 | BRSK2 | 0.47837616 |
| 86 | MUSK | 0.47528591 |
| 87 | CAMK2G | 0.47330676 |
| 88 | KSR2 | 0.46700632 |
| 89 | NUAK1 | 0.46080486 |
| 90 | CDK4 | 0.46021507 |
| 91 | BMPR1B | 0.45692679 |
| 92 | GRK1 | 0.45570145 |
| 93 | PRKG2 | 0.44753825 |
| 94 | MAP3K8 | 0.44465922 |
| 95 | CAMK2A | 0.44119822 |
| 96 | PRKACG | 0.42345096 |
| 97 | CAMK4 | 0.41930377 |
| 98 | ROCK2 | 0.40947729 |
| 99 | ABL2 | 0.40646056 |
| 100 | MAP2K4 | 0.39322390 |
| 101 | FGFR1 | 0.38348394 |
| 102 | MAPK11 | 0.37777963 |
| 103 | RET | 0.37310997 |
| 104 | PAK2 | 0.37092945 |
| 105 | PRKACB | 0.36673155 |
| 106 | MAP2K2 | 0.36099937 |
| 107 | MAP3K10 | 0.35466436 |
| 108 | MAPK12 | 0.33184797 |
| 109 | PDPK1 | 0.31830110 |
| 110 | AURKB | 0.31186081 |
| 111 | MAP4K2 | 0.30686675 |
| 112 | CAMK2B | 0.30570544 |
| 113 | TGFBR1 | 0.28902553 |
| 114 | PIK3CG | 0.28020129 |
| 115 | MAP3K9 | 0.27960212 |
| 116 | ERBB3 | 0.27738671 |
| 117 | CSNK1E | 0.27667581 |
| 118 | STK10 | 0.27219528 |
| 119 | LRRK2 | 0.26946598 |
| 120 | TGFBR2 | 0.25678986 |
| 121 | PAK4 | 0.25604132 |
| 122 | MAP3K6 | 0.25299177 |
| 123 | PRKD3 | 0.25271184 |
| 124 | WNK1 | 0.24652061 |
| 125 | ERBB2 | 0.24621107 |
| 126 | PRKACA | 0.24533330 |
| 127 | PRKCE | 0.23843288 |
| 128 | PRKCI | 0.23064554 |
| 129 | BCR | 0.18565324 |
| 130 | EPHB1 | 0.16685980 |
| 131 | ADRBK1 | 0.16248132 |
| 132 | RPS6KC1 | 0.15757624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.12924181 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.62999380 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.62842194 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.27281438 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.21291780 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.93414972 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.76082989 |
| 8 | Carbon metabolism_Homo sapiens_hsa01200 | 2.44068455 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.38583994 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.35964206 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.28893156 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.14514832 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.13612990 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.07819486 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.03966703 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.00518989 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.00084653 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92315848 |
| 19 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.80595313 |
| 20 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.76976051 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.64069845 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.62555042 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.62213353 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.52862437 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50930225 |
| 26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.49925992 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.46060093 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.44996813 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.43326470 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.43312574 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40729480 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.34312255 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32784837 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.30274645 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.29854596 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26054289 |
| 37 | Mineral absorption_Homo sapiens_hsa04978 | 1.22542179 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21600895 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19475282 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18718159 |
| 41 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.17561713 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.16668925 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14902730 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.14594618 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12654173 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08726607 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04476378 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.04080561 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 1.03092885 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.00816030 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00765780 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 0.98629867 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.96278135 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94087092 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93233068 |
| 56 | Huntingtons disease_Homo sapiens_hsa05016 | 0.92750548 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92198270 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92092602 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87613802 |
| 60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.80441085 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78547442 |
| 62 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.78431802 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78396994 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78157559 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77204187 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76593613 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75838052 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75067649 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73833764 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73681393 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70763111 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69563634 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.68840439 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67938565 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.65762921 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62520013 |
| 77 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.61144870 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60996795 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57815914 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55217803 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52547384 |
| 82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51979896 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.51866870 |
| 84 | Adherens junction_Homo sapiens_hsa04520 | 0.51645795 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51012418 |
| 86 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50357590 |
| 87 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.49498907 |
| 88 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49406019 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49198322 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49098675 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48114670 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.46871211 |
| 93 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.44470031 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.44203504 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44049029 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43217286 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42718176 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42309015 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41630663 |
| 100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41270197 |
| 101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37389063 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37249838 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36098417 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34992885 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32508156 |
| 106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.31538595 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31176902 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30221183 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.28343571 |
| 110 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.27968280 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27434417 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.24643847 |
| 113 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.23658525 |
| 114 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.22042525 |
| 115 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.21254820 |
| 116 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.20370710 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.17408463 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.16076672 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11321273 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.11193464 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.07884783 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.06379817 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.06135146 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.03715838 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.03167114 |

